The 2020 Focused Updates to the Asthma Management Guidelines: A Report from the
National Asthma Education and Prevention Program Coordinating Committee Expert Panel …

Background Maintenance treatment with long‐acting beta 2‐agonists and inhaled
corticosteroids (LABA/ICS) can relieve asthma symptoms and reduce the frequency of …

The 2020 National Asthma Education and Prevention Program Coordinating Committee
Expert Panel Working Group (NAEPP [2020 Focused Asthma Update]) guidelines and the …

Importance Long-acting muscarinic antagonists (LAMAs) are a potential adjunct therapy to
inhaled corticosteroids in the management of persistent asthma. Objective To conduct a …

In the current study electrospraying methodology was used for particle engineering of
montelukast and budesonide to prepare a combined inhalable dry powder formulation …

A rigorous process was undertaken to develop these evidence-based guidelines. The
Agency for Healthcare Research and Quality's (AHRQ) Evidence-Based Practice Centers …

Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus
addition of long‐acting beta2‐agonists (LABA) for adults with asthma - Kew, KM - 2015 …

ABSTRACT Introduction According to Global Initiative for Asthma (GINA) guidelines, long-
acting muscarinic antagonists (LAMAs) should be considered as add-on therapy in patients …

This pooled analysis of double-blind, randomized, placebo-controlled trials aimed to
investigate the impact of DOxofylline compaRed tO THEOphylline (DOROTHEO 1 and …

Background Oral methylxanthines are effective drugs for the treatment of chronic obstructive
respiratory disorders. The novel methylxanthine doxofylline, that has bronchodilator and anti …